Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials

American Heart Journal

Volumn 158, Issue 1, 2009, Pages 15-20

  Dagres, Nikolaos ^a   Varounis, Christos ^a   Flevari, Panayota ^a   Piorkowski, Christopher ^b   Bode, Kerstin ^b   Rallidis, Loukianos S ^a   Tsougos, Elias ^a   Leftheriotis, Dionyssios ^a   Sommer, Philipp ^b   Hindricks, Gerhard ^b   Kremastinos, Dimitrios Th ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CATHETER ABLATION; CLINICAL TRIAL; COMPARATIVE ANATOMY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW; STROKE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STROKE; SURVIVAL ANALYSIS;

EID: 67049109037     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.05.012     Document Type: Review

References (21)

1. Vidaillet H., Granada J.F., Chyou P.H., et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 113 (2002) 365-370
2. Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
3. Van Gelder I.C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
4. Corley S.D., Epstein A.E., DiMarco J.P., et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109 (2004) 1509-1513
5. Lafuente-Lafuente C., Mouly S., Longas-Tejero M.A., et al. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation. A systematic review of randomized controlled trials. Arch Intern Med 166 (2006) 719-728
6. Nair G.M., Nery P.B., Diwakaramenon S., et al. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol 20 (2009) 138-144
7. Pappone C., Rosanio S., Augello G., et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42 (2003) 185-197
8. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials 17 (1996) 1-12
9. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 (1999) 1896-1900
10. Wazni O.M., Marrouche N.F., Martin D.O., et al. Radiofrequency ablation versus antiarrhythmic drugs as first-line treatment for symptomatic atrial fibrillation. A randomized trial. J Am Med Assoc 293 (2005) 2634-2640
11. Oral H., Pappone C., Chugh A., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 354 (2006) 934-941
12. Pappone C., Augello G., Sala S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 48 (2006) 2340-2347
13. Stabile G., Bertaglia E., Senatore G., et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J 27 (2006) 216-221
14. Jaïs P., Cauchemez B., Macle L., et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118 (2008) 2498-2505
15. Forleo G.B., Mantica M., De Luca L., et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 20 (2009) 22-28
16. Krittayaphong R., Raungrattanaamporn O., Bhuripanyo K., et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai 86 Suppl 1 (2003) S8-S16
17. Wilber D.J., Pappone C., Neuzil P., et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: the ThermoCool AF Trial. Circulation 118 (2008) 2316 [abstract]
18. Wilber D.J., Pappone C., Neuzil P., et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: the ThermoCool AF Trial. Available at:. http://scientificsessions.americanheart.org/includes/pdfs/wilber.pdf Last accessed January 28, 2009
19. Nademanee K., Schwab M.C., Kosar E.M., et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 51 (2008) 843-849
20. Roy D., Talajic M., Nattel S., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358 (2008) 2667-2677
21. Miller J.M., Bhakta D., and Das M.K. The trials and tribulations of fibrillation ablation. J Cardiovasc Electrophysiol 20 (2009) 145-146